STA
DRTS icon

Summit Trail Advisors’s Alpha Tau Medical DRTS Stock Holding History

Summit Trail Advisors’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,270
Closed -$30.3K – 631
2024
Q1 		$30.3K Hold
10,270
– – ﹤0.01% 599
2023
Q4 		$30.9K Hold
10,270
– – ﹤0.01% 552
2023
Q3 		$38.9K Hold
10,270
– – ﹤0.01% 538
2023
Q2 		$44.9K Buy
+10,270
New +$36.8K ﹤0.01% 534
2023
Q1 		– Sell
-10,270
Closed -$32.7K – 403
2022
Q4 		$32.7K Buy
+10,270
New +$42.5K ﹤0.01% 400

Other funds holding DRTS

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

Summit Trail Advisors's DRTS Position: Q2 2024 in Review

Summit Trail Advisors sold out of Alpha Tau Medical (DRTS) in Q2 2024, closing a stake of 10,270 shares — an estimated $30.3K sold.

Summit Trail Advisors first reported a position in DRTS in Q4 2022 and held it in 5 quarters. The position peaked at $44.9K in Q2 2023. 24 funds tracked by Wall St. Rank hold DRTS as of Q2 2024.

  • Summit Trail Advisors reported no remaining Alpha Tau Medical position as of Q2 2024 after selling out during the quarter.
  • Summit Trail Advisors sold 10,270 Alpha Tau Medical shares in Q2 2024, an estimated $30.3K.
  • Summit Trail Advisors first reported a position in Alpha Tau Medical in Q4 2022 and held it in 5 quarters.
  • Summit Trail Advisors's Alpha Tau Medical position peaked at $44.9K in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2024.

Based on Summit Trail Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.